Stellantis names Italian car executive Antonio Filosa its new CEO
Filosa, who is currently Stellantis' chief operating officer for the Americas and chief quality officer, takes the post effective June 23, when he is expected to announce his leadership team.
The move returns the running of Stellantis, created from the 2021 merger of France's PSA Peugeot with Italian-US carmaker Fiat Chrysler Automobiles, to Italian hands after three years under Tavares, who previously served as Peugeot's top executive. John Elkann, heir to the Fiat-founding Agnelli family, remains chairman.
Elkann praised Filosa's 'deep understanding of our company, including its people, who he views as our core strength, and of our industry.'
Robert Peugeot said the board's choice was unanimous, calling Filosa a 'natural choice' due to his leadership track record and knowledge of the business and 'the complex dynamics facing our industry.'
Filosa joined Fiat in 1999, spending much of his career in Latin America where held positions from plant manager to head of purchasing and later chief operating officer. He was credited with making the Fiat brand the regional market leader and boosting the market share of the Peugeot, Citroen, Ram and Jeep brands.
He was promoted to chief operating officer of the Americas in 2024 in an executive shakeup as sales slumped in North America, its main source of profits.
Stellantis has been lagging globally in the transition to electric powertrains and facing stiff Chinese competition. Analysts also have said Stellantis, with 14 brands, is yoked by too many under-performers, including Maserati and Chrysler.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
IREN Limited (IREN)'s Shares Have Nearly Doubled This Year. Here Is What You Need To Know
IREN Limited (NASDAQ:IREN) is among the 12 Best Australian Stocks to Buy Right Now. The stock has had a stellar 2025, with year-to-date gains of 94%, as of the close of business on August 14. Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexels The wave has been fueled by impressive financial performance. IREN Limited (NASDAQ:IREN) in May posted a record revenue of $148.1 million during the third quarter of fiscal 2025, along with a 28% sequential increase in profit after tax. The robust results were driven by the company's focus on large-scale data center sites, which are driving strong growth and margins. The momentum has continued with the recent announcement of record monthly revenue and hardware profit for July, with a 17% increase in bitcoins mined and upgrades in AI cloud, bolstering bullish sentiment. Expansion projects have also thrilled investors, such as the $130 million purchase of 2.4k next-generation Blackwell B200 and B300 GPUs from NVIDIA last month. IREN Limited (NASDAQ:IREN) owns and operates data centers powering the future of Bitcoin and artificial intelligence using renewable energy. Wall Street analysts maintain a positive outlook for the stock, with a consensus Buy rating and an average share price upside potential of 16.8%. While we acknowledge the potential of IREN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Large Cap Defense Stocks to Buy According to Analysts and 10 Best Low Priced Defense Stocks to Buy Now. Disclosure: None. Sign in to access your portfolio
Yahoo
38 minutes ago
- Yahoo
Piper Sandler Reduces PT on lululemon athletica (LULU) Stock
lululemon athletica inc. (NASDAQ:LULU) is one of the Reddit Stocks with the Highest Upside Potential. On July 29, Piper Sandler reduced the price target on the company's stock to $200 from $270, while keeping a 'Neutral' rating, as reported by The Fly. As per the firm, the fall in lululemon athletica inc. (NASDAQ:LULU)'s shares this year was because of a correction in the multiple. In Q1 2025, the company achieved growth throughout its channels, categories, and markets, including the US, demonstrating the continued strength and agility of its business model. A store employee in an athletic apparel store restocking merchandise. Amidst the dynamic macro environment, lululemon athletica inc. (NASDAQ:LULU) plans to leverage its robust financial position and competitive advantages to play offense, while it continues to invest in growth opportunities. In Q1 2025, its net revenue rose 7% to $2.4 billion, or 8% on a constant dollar basis, with the Americas net revenue rising 3% and the International net revenue increasing 19%. For Q2 2025, lululemon athletica inc. (NASDAQ:LULU) anticipates net revenue of between $2.535 billion – $2.560 billion, reflecting growth of 7% – 8%. RGA Investment Advisors, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'Late in the quarter, we purchased shares in Lululemon athletica inc. (NASDAQ:LULU), despite uncertainty about the tariff situation. Many of you are familiar with the brand. Lulu is a leading athleisure brand and though competition has increased from upstart offerings like Vuori, Alo and Fabletics, the company has continued to maintain relevance and perform admirably. These upstarts have varied approaches, but in aggregate, they have won share with a combination of faster, more tasteful fashion and cheaper prices. Importantly, this share has predominantly come from Nike–the 10,000 pound gorilla of the industry that continues to see negative topline growth. Even within the competitive landscape, it is notable that Vuori and Alo enthusiasts still consider Lulu core to their wardrobe, given the demonstrable quality advantage of the company's proprietary fabrics. Although Lulu has benefited from dominance in fashion, its core calling has been performance and that segment of the market remains unquestioned. While we acknowledge the potential of LULU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
38 minutes ago
- Yahoo
Novo Nordisk A/S (NVO) Delivers 18% Sales Growth in H1 2025
Novo Nordisk A/S (NYSE:NVO) is one of the Reddit Stocks with the Highest Upside Potential. On August 6, the company stated that it delivered 18% sales growth in H1 2025. The company has lowered its full-year outlook because of lower growth expectations for its GLP-1 treatments in H2 2025. Therefore, it has been taking measures to sharpen its commercial execution further, and ensure efficiencies in its cost base while continuing to make investments in future growth. With over 1 billion people living with obesity globally, which includes over 100 million living in the US, and only a few million on treatment, Novo Nordisk A/S (NYSE:NVO) expects to maximise the strong growth opportunities, thanks to the healthy product portfolio and future pipeline. A closeup shot of a laboratory technician handling a medical device used for fertility treatments. Novo Nordisk A/S (NYSE:NVO) highlighted that the sales within Diabetes and Obesity care rose 16% in Danish kroner to DKK 145.4 billion (and 18% at CER), mainly due to the Obesity care growth of 56% in Danish kroner to DKK 38.8 billion (and 58% at CER) and GLP-1 diabetes sales increasing 8% in Danish kroner (10% at CER). Within R&D, Novo Nordisk A/S (NYSE:NVO) plans to advance subcutaneous and oral amycretin into phase 3 development in weight management on the basis of completed clinical studies during Q1 2025. For FY 2025, the sales growth is anticipated to be 8% – 14% at CER, and operating profit growth is projected to be 10% – 16% at CER. ClearBridge Investments, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'We initiated a new position in Novo Nordisk A/S (NYSE:NVO), the global leader in diabetes care and one of two dominant players in the fast-growing GLP-1 diabetes and obesity drug market. A slowdown in prescriptions for Novo's GLP-1 drugs, combined with confusion surrounding a clinical trial of its next-generation candidate, CagriSema, caused a significant pullback in the stock. We saw this as a buying opportunity. We believe the GLP-1 market remains vast and that Novo (alongside Eli Lilly) is well-positioned to maintain a duopolistic structure for years to come, given the complexity of manufacturing, differentiated intellectual property and brand strength. We also expect growth to reaccelerate as supply ramps up following its acquisition of Catalent and as regulators crack down on unlicensed compounders.' While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
